Corporate governance
We are fully committed to good corporate governance. Our principles and rules on corporate governance are laid down in the articles of association and the organizational regulations, among other documents.
Explore recordings and documents from the meetings
The next Annual General Meeting will take place on May 6, 2025 in Kaiseraugst, Switzerland.
The Annual General Meeting of DSM-Firmenich AG took place on 7 May 2024 at the company’s head offices at Wurmisberg 576, 4303 Kaiseraugst, Switzerland. All resolutions on the agenda were approved by the shareholders.
Annual General Meetings (EN)
Annual General Meetings (DE)
Annual General Meetings (NL)
Annual General Meetings (FR)
Voting results
Invitation to the Annual General Meeting
Voting instructions can be provided through this link.
AGM minutes
Integrated Annual Report 2023
Sustainability Report 2023 (Extract from the Integrated Annual Report 2023)
Compensation Report 2023 (Extract from the Integrated Annual Report 2023)
Shareholder meeting user manual
Shareholder meeting Q&As
Policy on use of electronic means at Hybrid Meetings
The extraordinary general meeting of shareholders was held on June 29, 2023 at the company offices at Wurmisweg 576, 4303 Kaiseraugst, Switzerland. All resolutions on the agenda were approved by the shareholders.
The shareholders or shareholder representatives voted on 197,464,498 shares or 74.45% of the issued share capital entitled to vote. Number of votes per share is 1 and the number of outstanding shares on 29 June 2023, the date of the meeting, was 265,217,171.
EGM (EN)
EGM (DE)
EGM (NL)
EGM (FR)
Approval of the stand-alone interim financial statements of DSM-Firmenich AG for the period from 1 January 2023 to 8 May 2023
For | Against | Abstain | Total | |
Votes | 195,384,208 | 1,200,493 | 879,797 | 197,464,498 |
% | 98.95% | 0.61% | 0.45% |
Dividend / Distribution of Capital Contribution Reserves
For | Against | Abstain | Total | |
Votes | 197,445,780 | 8,293 | 10,425 | 197,464,498 |
% | 99.99% | 0.00% | 0.01% |
Approval of remuneration for the Board of Directors
For | Against | Abstain | Total | |
Votes | 195,384,208 | 4,485,119 | 1,076,031 | 197,464,498 |
% | 97.18% | 2.27% | 0.54% |
Approval of the remuneration of the Executive Committee
For | Against | Abstain | Total | |
Votes | 191,489,400 | 4,476,258 | 1,498,840 | 197,464,498 |
% | 96.97% | 2.27% | 0.76% |
Approval of certain important transactions by shareholders
For | Against | Abstain | Total | |
Votes | 185,937,469 | 3,530,633 | 7,996,396 | 97,464,498 |
% | 94.16% | 1.79% | 4.05% |
Possibility of the Board of Directors to request custodians to disclose the identity of shareholders and beneficial owners
For | Against | Abstain | Total | |
Votes | 184,157,906 | 3,790,079 | 9,516,513 | 197,464,498 |
% | 93.26% | 1.92% | 4.82% |
Invitation to the extraordinary general meeting
Voting instructions can be provided through this link.
EGM presentation - 29 June 2023
EGM minutes
Interim Financial Statements
Remuneration at dsm-firmenich
Statement on BoD and Exco remuneration (ENG)
Statement on BoD and Exco remuneration (NL)
Articles of association (with proposed amendments highlighted)
Article of association (with proposed amendments)
Policy on use of electronic means
Hybrid meeting shareholder manual
Hybrid meeting Q&A's
We would love to hear from you! If you have any questions, please contact us via e-mail button below.
We are fully committed to good corporate governance. Our principles and rules on corporate governance are laid down in the articles of association and the organizational regulations, among other documents.
Sustainability is fundamental to how dsm-firmenich brings progress to life – for people and planet.
Two global leaders in science and innovation have joined forces to become dsm-firmenich, creating a world of potential for investors.